No definition available.
Congenital malformations of the musculoskeletal system, not elsewhere classified
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
540 |
4. Check minimum number of eventsNone |
540 |
5. Include endpointsNone |
540 |
6. Filter based on genotype QC (FinnGen only) |
540 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Malformationes congenitae systematis musculosceletalis non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Congenital malformations of the musculoskeletal system, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3921 | 2562 | 1350 |
| Only index persons | 3291 | 2268 | 1023 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.04 |
| Only index persons | 0.07 | 0.08 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 22.80 | 30.56 | 8.01 |
| Only index persons | 27.31 | 33.04 | 14.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 540 | 453 | 87 |
| Unadjusted period prevalence (%) | 0.14 | 0.15 | 0.04 |
| Median age at first event (years) | 37.60 | 38.29 | 33.99 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 464
- Matched controls
- 4641
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
2312.7
323.0
313
*
M35.7
ICD-10 Finland
Hypermobility syndrome
54.5
128.4
152
41
Z31.5
ICD-10 Finland
Genetic counselling
10.9
72.1
151
196
R4120
NOMESCO Finland
Occupational therapy
11.6
52.1
102
110
Q79.00
ICD-10 Finland
Congenital anterior diaphragmatic hernia
+∞
51.0
48
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
8.9
47.9
110
157
N02AX02
ATC
tramadol; systemic, rectal
4.0
42.8
245
1005
N03AX16
ATC
pregabalin; oral
4.7
42.5
179
548
L28
ICPC
Limited function/disability (L)
6.7
42.4
120
231
N06AX21
ATC
duloxetine; oral
6.1
41.9
128
272
N03AX12
ATC
gabapentin; oral
5.6
41.8
139
328
Q79.8
ICD-10 Finland
Other congenital malformations of musculoskeletal system
+∞
41.3
39
*
R4110
NOMESCO Finland
Physiotherapy
4.3
39.7
186
624
M25.5
ICD-10 Finland
Pain in joint
3.7
35.4
211
855
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.8
31.7
120
316
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
5.4
30.9
101
226
Z3226
NOMESCO Finland
Physiotherapist
4.1
30.8
142
452
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
8.8
30.5
68
89
M79.7
ICD-10 Finland
Fibromyalgia
9.1
27.3
59
73
SPAT1229
SPAT
Assessment of need for aid
7.3
27.1
68
107
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.8
26.7
81
164
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.2
26.4
88
199
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
26.3
210
994
Z3231
NOMESCO Finland
Registered nurse
3.1
24.9
177
770
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
24.8
155
615
L99
ICPC
Musculoskeletal disease other
14.3
24.7
42
32
A02BC05
ATC
esomeprazole; systemic
2.9
24.3
217
1089
M79.0
ICD-10 Finland
Rheumatism, unspecified
8.2
24.0
55
75
R03AC02
ATC
salbutamol; inhalant
2.8
24.0
311
1954
K07.60
ICD-10 Finland
Snapping jaw
5.3
23.9
77
167
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
23.8
200
964
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
23.4
112
358
N02AA05
ATC
oxycodone; systemic
5.0
23.3
80
186
A28
ICPC
Limited function/disability NOS
5.4
23.2
74
158
Q79.9
ICD-10 Finland
Congenital malformation of musculoskeletal system, unspecified
+∞
23.1
22
*
XF404
NOMESCO Finland
Ambulatory ECG
5.8
22.8
68
134
Z2446
NOMESCO Finland
Social worker
4.9
22.7
79
186
M79.1
ICD-10 Finland
Myalgia
3.7
22.5
111
363
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
3.2
22.2
140
552
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
21.9
232
1269
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
16.4
21.9
35
23
R51.80
ICD-10 Finland
Headache
3.3
21.9
131
497
M03BX01
ATC
baclofen; systemic
14.3
21.9
37
28
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
3.6
21.7
111
373
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
14.9
21.7
36
26
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.1
21.5
61
113
M79.6
ICD-10 Finland
Pain in limb
2.7
21.2
202
1033
G93.3
ICD-10 Finland
Postviral fatigue syndrome
31.7
20.8
27
9
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
6.7
20.7
54
89
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.5
20.7
78
199
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
20.6
137
555
N06AX16
ATC
venlafaxine; oral
3.4
20.4
114
408
A01
ICPC
Pain general/multiple sites
5.2
19.8
64
138
ZY010
NOMESCO Finland
Hospital outpatient
4.8
19.7
69
163
A03FA01
ATC
metoclopramide; systemic, rectal
3.1
19.6
125
489
Z2445
NOMESCO Finland
Psychologist
5.6
19.5
59
118
R52.2
ICD-10 Finland
Other chronic pain
7.2
19.2
47
71
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.4
19.2
103
356
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
4.0
19.0
82
237
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.8
18.7
153
701
J45.9
ICD-10 Finland
Asthma, unspecified
3.0
18.7
124
497
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
18.6
235
1374
R06.0
ICD-10 Finland
Dyspnoea
2.9
18.3
132
560
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.2
18.2
58
123
N06AA09
ATC
amitriptyline; systemic
4.4
18.0
69
178
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
17.9
140
623
Q79.2
ICD-10 Finland
Exomphalos
+∞
17.8
17
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
6.0
17.5
49
89
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
17.5
157
754
C07AB07
ATC
bisoprolol; oral
2.6
17.5
167
832
M54.5
ICD-10 Finland
Low back pain
2.4
17.4
195
1060
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.2
17.2
69
186
WX002
NOMESCO Finland
Sedation and analgesia
3.1
17.2
106
402
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.4
17.1
64
161
Z2221
NOMESCO Finland
Medical doctor
2.5
17.0
172
883
A02BC02
ATC
pantoprazole; systemic
2.3
16.9
288
1917
Q79.3
ICD-10 Finland
Gastroschisis
+∞
16.8
16
*
C07AA05
ATC
propranolol; systemic
2.7
16.8
138
629
C01CA24
ATC
epinephrine; parenteral
3.8
16.5
75
225
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.9
16.5
47
87
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
15.0
16.5
27
19
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.6
16.3
48
93
G44.0
ICD-10 Finland
Cluster headache syndrome
21.9
16.1
23
11
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.9
16.1
111
452
N02BE01
ATC
paracetamol; systemic, rectal
2.8
16.1
398
3165
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.6
16.1
57
136
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
16.0
60
151
Q79.01
ICD-10 Finland
Congenital posteriolateral diaphragmatic hernia
+∞
15.7
15
*
H02AB07
ATC
prednisone; oral
3.3
15.5
85
295
M54.4
ICD-10 Finland
Lumbago with sciatica
2.9
15.5
105
422
G43.9
ICD-10 Finland
Migraine, unspecified
3.7
15.4
71
216
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
15.4
228
1397
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.0
15.3
50
109
R53
ICD-10 Finland
Malaise and fatigue
2.7
15.3
123
549
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
4.6
15.3
54
128
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
15.1
199
1149
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.2
15.1
84
296
N04BC09
ATC
rotigotine; transdermal
82.8
14.7
16
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
14.6
67
203
A02BA02
ATC
ranitidine; systemic
2.9
14.5
96
379
Z50.1
ICD-10 Finland
Other physical therapy
5.8
14.4
41
76
H02AB06
ATC
prednisolone; systemic
2.2
14.4
222
1368
L29
ICPC
Musculoskeletal sympt/complt other
4.2
14.4
57
151
G47.3
ICD-10 Finland
Sleep apnoea
2.9
14.4
95
374
M01AH01
ATC
celecoxib; oral (coxibs)
3.1
14.3
88
330
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.7
14.3
41
77
G44.2
ICD-10 Finland
Tension-type headache
2.9
14.3
99
403
ZXE00
NOMESCO Finland
One hour or less
2.2
14.3
217
1329
J01FF01
ATC
clindamycin; systemic
2.5
14.1
135
661
N05AH04
ATC
quetiapine; oral
2.6
14.1
114
508
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.3
14.1
54
139
N03AE01
ATC
clonazepam; systemic
5.1
14.1
45
96
ZXA05
NOMESCO Finland
Left side
2.7
14.0
113
502
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
14.0
102
426
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
13.9
187
1080
UKC02
NOMESCO Finland
Cystoscopy
3.6
13.8
64
195
UJF32
NOMESCO Finland
Coloscopy
2.6
13.8
112
500
Q79.10
ICD-10 Finland
Eventration of diaphragm
+∞
13.6
13
*
R51.81
ICD-10 Finland
Facial pain NOS
8.5
13.5
29
36
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
13.3
74
259
R5140
NOMESCO Finland
Monitoring the use of the aid
4.2
13.2
51
132
N03AX09
ATC
lamotrigine; oral
4.2
13.1
51
133
SPAT1216
SPAT
Assessment of functional ability
3.3
13.0
68
228
M24.2
ICD-10 Finland
Disorder of ligament
8.9
12.9
27
32
R06AE07
ATC
cetirizine; oral
2.1
12.9
248
1651
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
12.9
114
529
R00.2
ICD-10 Finland
Palpitations
3.7
12.9
57
167
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.5
12.7
45
107
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
12.7
111
513
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.2
12.7
49
127
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.2
12.7
70
243
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
5.0
12.7
41
89
M01AE03
ATC
ketoprofen; systemic, rectal
2.2
12.6
167
949
XA800
NOMESCO Finland
Neuropsychological investigation
4.8
12.6
42
94
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.5
12.6
37
72
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.4
12.5
64
211
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.5
12.4
60
189
SPAT1231
SPAT
Assessment of adjustments needed in living environment
16.4
12.2
19
12
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.8
12.1
86
350
XA402
NOMESCO Finland
ENMG
7.1
12.1
29
43
N03AX11
ATC
topiramate; oral
5.7
12.0
34
63
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
12.0
64
217
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
12.0
177
1048
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.9
12.0
33
59
SBB10
NOMESCO Finland
Teeth copy
3.1
11.9
71
259
M22.0
ICD-10 Finland
Recurrent dislocation of patella
8.7
11.9
25
30
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.0
11.9
23
24
A06AC01
ATC
ispaghula (psylla seeds); oral
2.4
11.8
113
547
R5599
NOMESCO Finland
Other rehabilitation service
7.5
11.7
27
38
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
9.0
11.7
24
28
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
11.6
102
472
G54.0
ICD-10 Finland
Brachial plexus disorders
5.8
11.6
32
58
Q76.9
ICD-10 Finland
Congenital malformation of bony thorax, unspecified
+∞
11.5
11
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.4
11.5
56
178
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.1
11.4
45
119
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.8
11.4
79
318
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
5.2
11.4
35
72
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
3.0
11.4
69
256
M03BC01
ATC
orphenadrine (citrate); systemic
2.2
11.3
138
746
J01AA02
ATC
doxycycline; systemic
2.1
11.3
339
2632
A02BC03
ATC
lansoprazole; oral
2.3
11.3
125
646
WX402
NOMESCO Finland
General anaesthesia
2.4
11.3
105
500
M89.0
ICD-10 Finland
Algoneurodystrophy
13.1
11.2
19
15
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.2
11.1
34
70
A04
ICPC
Weakness/tiredness general
2.7
11.0
83
351
Z3229
NOMESCO Finland
Other healthcare associate professional
3.7
11.0
49
145
ZX120
NOMESCO Finland
Intravenous
3.4
11.0
54
173
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.8
10.9
73
287
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
10.9
96
444
J45
ICD-10 Finland
Asthma
2.9
10.9
69
261
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.1
10.9
63
227
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
10.9
10.9
20
19
J01EA01
ATC
trimethoprim; systemic
2.1
10.8
142
792
Z71.8
ICD-10 Finland
Other specified counselling
2.1
10.8
147
833
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
10.7
59
203
R03BA02
ATC
budesonide; inhalant
2.3
10.7
106
521
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.1
10.6
28
48
P01AB01
ATC
metronidazole; oral, rectal
2.0
10.6
202
1310
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
10.5
53
173
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
10.5
98
467
C08DA01
ATC
verapamil; systemic
5.6
10.5
30
57
N05CF01
ATC
zopiclone; oral
2.2
10.5
129
698
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.4
10.4
24
34
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
10.4
104
513
XKD00
NOMESCO Finland
Uroflowmetry
3.6
10.4
47
141
J01FA06
ATC
roxithromycin; oral
2.0
10.4
194
1246
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
10.3
71
286
M54.2
ICD-10 Finland
Cervicalgia
3.3
10.3
52
170
ZXA10
NOMESCO Finland
Bilateral
2.4
10.3
90
415
M54.6
ICD-10 Finland
Pain in thoracic spine
3.2
10.3
54
182
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.0
10.3
189
1205
R02
ICPC
Shortness of breath/dyspnoea
2.8
10.2
69
271
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
10.2
179
1121
R20.2
ICD-10 Finland
Paraesthesia of skin
3.3
10.2
51
166
N06AX11
ATC
mirtazapine; oral
2.0
10.2
152
893
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.2
10.1
53
178
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.8
10.1
69
275
U07
ICPC
Urine symptom/complaint other
4.4
10.1
36
87
N04BC05
ATC
pramipexole; oral
3.9
10.1
41
112
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.4
10.1
50
161
N02CC03
ATC
zolmitriptan; nasal, oral
3.4
10.1
50
161
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.1
10.1
56
194
G43.3
ICD-10 Finland
Complicated migraine
7.0
10.0
24
36
T78.4
ICD-10 Finland
Allergy, unspecified
3.5
10.0
47
145
AA1AD
NOMESCO Finland
CT of head and brain
2.5
10.0
83
371
R51
ICD-10 Finland
Headache
3.6
9.9
45
135
J01FA10
ATC
azithromycin; systemic
1.9
9.9
318
2463
R1250
NOMESCO Finland
Evaluation of functional capability
7.3
9.9
23
33
J01DB01
ATC
cefalexin; oral
2.2
9.9
387
3240
M03BC51
ATC
orphenadrine, combinations; systemic
2.1
9.9
139
795
N05BA01
ATC
diazepam; systemic, rectal
2.7
9.8
70
285
N06AB06
ATC
sertraline; oral
2.6
9.8
77
335
M01AH02
ATC
rofecoxib; oral
3.0
9.7
57
207
M03BX02
ATC
tizanidine; oral
1.9
9.7
290
2179
M22.4
ICD-10 Finland
Chondromalacia patellae
4.4
9.7
34
81
M47.82
ICD-10 Finland
Other spondylosis, cervical region
5.5
9.7
28
54
R42
ICD-10 Finland
Dizziness and giddiness
2.3
9.7
99
489
J98.6
ICD-10 Finland
Disorders of diaphragm
56.2
9.7
11
*
N06AB04
ATC
citalopram; systemic
2.2
9.6
109
568
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
10.4
9.6
18
18
R06AX22
ATC
ebastine; oral
2.3
9.6
101
509
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
15.4
9.6
15
10
R11
ICD-10 Finland
Nausea and vomiting
3.0
9.6
55
197
WX110
NOMESCO Finland
Local anesthesy
2.0
9.5
347
2794
R50.9
ICD-10 Finland
Fever, unspecified
2.4
9.5
83
382
R03DC03
ATC
montelukast; oral
2.2
9.5
106
548
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
9.4
168
1050
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
12.7
9.4
16
13
J01MA12
ATC
levofloxacin; systemic
2.5
9.4
76
332
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.4
9.4
27
52
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
11.0
9.4
17
16
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
11.0
9.4
17
16
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
9.3
70
295
Z01.9
ICD-10 Finland
Special examination, unspecified
4.2
9.3
34
85
R03BA05
ATC
fluticasone; inhalant
2.2
9.2
110
582
R52.1
ICD-10 Finland
Chronic intractable pain
14.0
9.2
15
11
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
14.0
9.2
15
11
R06AX27
ATC
desloratadine; oral
1.9
9.2
176
1127
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
9.2
223
1552
M25.2
ICD-10 Finland
Flail joint
7.3
9.1
21
30
M02AA07
ATC
piroxicam; topical
2.0
9.1
143
847
N02CC05
ATC
almotriptan; oral
3.4
9.1
43
134
M01AH05
ATC
etoricoxib; oral
1.8
9.1
260
1906
R4190
NOMESCO Finland
Nutritional therapy
3.6
9.1
40
118
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
9.0
103
534
D07AD01
ATC
clobetasol; topical
2.5
9.0
74
325
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.6
9.0
30
68
ZXA00
NOMESCO Finland
Right side
2.2
9.0
103
537
B02AA02
ATC
tranexamic acid; systemic
2.2
9.0
97
492
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.9
9.0
56
212
A02BC01
ATC
omeprazole; systemic
2.1
9.0
124
698
G50.1
ICD-10 Finland
Atypical facial pain
8.2
8.9
19
24
XQ800
NOMESCO Finland
Prick test
2.7
8.9
65
268
M22.1
ICD-10 Finland
Recurrent subluxation of patella
12.9
8.9
15
12
M01AC06
ATC
meloxicam; systemic, rectal
2.0
8.9
148
898
L20
ICPC
Joint symptom/complaint NOS
5.3
8.9
26
51
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.9
8.9
161
1008
R13
ICD-10 Finland
Dysphagia
4.0
8.8
34
89
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
8.8
70
303
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.2
8.8
26
52
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
5.7
8.7
24
44
L03
ICPC
Low back symptom/complaint
2.0
8.7
124
708
N06AX17
ATC
milnacipran; oral
11.9
8.6
15
13
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
8.6
72
322
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
16.7
8.6
13
8
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.8
8.6
55
212
N06AX22
ATC
agomelatine; oral
5.6
8.6
24
45
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.6
8.5
19
26
N02CC07
ATC
frovatriptan; oral
3.6
8.5
37
108
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
8.5
121
690
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
8.5
50
183
A04AA01
ATC
ondansetron; systemic, rectal
3.4
8.5
40
125
N03AG01
ATC
valproic acid; systemic, rectal
3.4
8.5
40
125
F50.9
ICD-10 Finland
Eating disorder, unspecified
6.4
8.4
21
34
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
8.4
53
202
J02AC01
ATC
fluconazole; systemic
1.8
8.4
224
1588
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.5
8.4
38
115
A03FA02
ATC
cisapride; oral, rectal
3.5
8.3
38
116
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.7
8.3
20
31
R06AE09
ATC
levocetirizine; oral
2.2
8.3
92
471
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.4
8.2
39
122
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.3
8.2
40
128
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.5
8.2
69
308
N30.0
ICD-10 Finland
Acute cystitis
2.3
8.2
79
380
N81.6
ICD-10 Finland
Rectocele
3.4
8.2
39
123
J01MA02
ATC
ciprofloxacin; systemic
1.9
8.2
151
946
R33
ICD-10 Finland
Retention of urine
5.2
8.1
24
48
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.3
8.1
40
129
G81.9
ICD-10 Finland
Hemiplegia, unspecified
12.0
8.1
14
12
J20
ICD-10 Finland
Acute bronchitis
2.8
8.1
54
212
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
8.1
264
1987
L02
ICPC
Back symptom/complaint
2.6
8.1
61
259
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
8.1
140
858
G43
ICD-10 Finland
Migraine
3.1
8.0
45
157
H04.10
ICD-10 Finland
Dry eye syndrome
2.6
8.0
57
233
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
8.0
121
705
JAH01
NOMESCO Finland
Laparoscopy
3.6
8.0
35
103
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
8.0
46
166
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
8.0
46
166
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.6
7.9
22
41
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
13.3
7.9
13
10
ZXD20
NOMESCO Finland
Day surgery
2.4
7.9
70
322
F45.8
ICD-10 Finland
Other somatoform disorders
2.5
7.9
62
268
M01AE02
ATC
naproxen; oral, rectal
1.7
7.9
283
2190
TKC20
NOMESCO Finland
Catheterisation of bladder
4.0
7.8
30
79
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
6.6
7.8
19
30
R5110
SPAT
NA
6.6
7.8
19
30
R4130
NOMESCO Finland
Speech therapy
6.6
7.8
19
30
N06BA12
ATC
lisdexamfetamine; oral
15.4
7.7
12
8
X58
ICD-10 Finland
Exposure to other specified factors
2.3
7.7
78
380
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.5
7.7
35
106
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
7.7
46
170
SAA02
NOMESCO Finland
Basic examination of mouth
1.8
7.7
338
2769
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
10.3
7.6
14
14
K59.09
ICD-10 Finland
Constipation, unspecified
3.7
7.6
32
92
S43.0
ICD-10 Finland
Dislocation of shoulder joint
4.4
7.5
26
62
R52.9
ICD-10 Finland
Pain, unspecified
2.7
7.5
52
210
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.2
7.5
22
44
M50.3
ICD-10 Finland
Other cervical disc degeneration
6.6
7.5
18
28
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
7.5
65
297
F48.0
ICD-10 Finland
Neurasthenia
81.3
7.4
8
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
7.4
70
333
F34.1
ICD-10 Finland
Dysthymia
3.9
7.4
29
78
N05CD07
ATC
temazepam; oral
2.9
7.4
44
163
JG1JB
NOMESCO Finland
Defekography with X-ray
11.1
7.3
13
12
J45.8
ICD-10 Finland
Mixed asthma
4.4
7.3
25
59
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
9.6
7.3
14
15
A02BA03
ATC
famotidine; systemic
5.6
7.3
20
37
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
5.6
7.3
20
37
M54.8
ICD-10 Finland
Other dorsalgia
4.1
7.3
27
69
3007
Kela drug reimbursment
Erenumab and fremanezumab
6.0
7.3
19
33
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.5
7.3
32
95
N06AB10
ATC
escitalopram; oral
1.9
7.3
120
717
XF402
NOMESCO Finland
ECG with work load test
3.1
7.2
39
135
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.8
7.2
155
1012
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
30.5
7.2
9
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
4.5
7.1
24
56
R1260
NOMESCO Finland
Evaluation of communicative skills
12.3
7.1
12
10
PD5BD
NOMESCO Finland
Extensive CT of aorta
12.3
7.1
12
10
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.1
7.1
38
131
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
9.0
7.1
14
16
R03BB04
ATC
tiotropium bromide; inhalant
3.2
7.1
35
114
S06.0
ICD-10 Finland
Concussion
2.5
7.1
55
237
R03AC03
ATC
terbutaline; inhalant
2.1
7.1
80
411
M53.2
ICD-10 Finland
Spinal instabilities
10.2
7.1
13
13
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
4.4
7.0
24
57
XG466
NOMESCO Finland
Sleep oxymetry
5.3
7.0
20
39
C03CA01
ATC
furosemide; systemic
2.3
7.0
65
307
N03AF01
ATC
carbamazepine; oral, rectal
3.8
7.0
28
77
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
6.5
7.0
17
27
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
7.0
259
1988
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
7.0
261
2007
N02CC04
ATC
rizatriptan; oral
2.6
6.9
48
194
RK110
NOMESCO Finland
NA
14.0
6.9
11
8
A06AC51
ATC
ispaghula, combinations; systemic
3.5
6.9
31
94
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
6.9
64
302
F60.9
ICD-10 Finland
Personality disorder, unspecified
6.9
6.9
16
24
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
6.9
54
235
A06AD11
ATC
lactulose; oral
2.6
6.8
50
207
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.9
6.8
40
146
R03AK07
ATC
formoterol and budesonide; inhalant
2.0
6.8
97
547
F84.5
ICD-10 Finland
Asperger syndrome
9.5
6.8
13
14
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
9.5
6.8
13
14
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.2
6.8
72
358
R03BA08
ATC
ciclesonide; inhalant
2.6
6.8
50
208
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
40.7
6.8
8
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
6.7
74
377
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.4
6.7
31
96
H02AB09
ATC
hydrocortisone; systemic
4.3
6.7
23
55
M70.6
ICD-10 Finland
Trochanteric bursitis
2.6
6.7
47
192
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
22.9
6.7
9
*
L13
ICPC
Hip symptom/complaint
2.3
6.7
60
278
G56.2
ICD-10 Finland
Lesion of ulnar nerve
4.7
6.7
21
46
J01DA01
ATC
[U] cefalexin; systemic
1.7
6.7
278
2193
SPAT1059
SPAT
Spirometry at the office
3.5
6.7
29
86
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
8.0
6.7
14
18
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
4.5
6.6
22
51
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
12.5
6.6
11
9
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
6.6
27
76
N80.9
ICD-10 Finland
Endometriosis, unspecified
4.1
6.6
24
61
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
6.6
236
1782
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.6
66
321
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.2
6.6
19
38
L12
ICPC
Hand/finger symptom/complaint
2.0
6.6
86
470
ZXD05
NOMESCO Finland
Urgent procedure
1.7
6.5
156
1046
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.4
6.5
30
93
R15
ICD-10 Finland
Faecal incontinence
5.8
6.5
17
30
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.8
6.5
26
72
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.0
6.5
35
122
D01
ICPC
Abdominal pain/cramps general
2.2
6.5
70
353
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
6.5
74
382
R06AX26
ATC
fexofenadine; oral
2.6
6.4
45
183
S73.0
ICD-10 Finland
Dislocation of hip
70.8
6.4
7
*
J01FA09
ATC
clarithromycin; systemic
1.7
6.4
155
1044
M23.5
ICD-10 Finland
Chronic instability of knee
14.6
6.4
10
7
R03AC13
ATC
formoterol; inhalant
3.8
6.4
25
68
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.4
259
2018
SPAT1097
SPAT
Recording of ECG
2.4
6.4
51
224
I34.1
ICD-10 Finland
Mitral (valve) prolapse
8.3
6.4
13
16
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
6.4
65
320
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.7
6.4
41
159
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
6.4
58
271
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.4
6.3
29
90
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.7
6.3
26
74
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
18.3
6.3
9
5
TQW40
NOMESCO Finland
Remowal of suture of skin
3.0
6.3
34
119
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.7
6.3
41
161
JAG10
NOMESCO Finland
Repair of gastroschisis
+∞
6.3
6
*
JAG20
NOMESCO Finland
Repair of omphalocele
+∞
6.3
6
*
JBB10
NOMESCO Finland
Repair of congenital diaphragmatic hernia
+∞
6.3
6
*
Q79.5
ICD-10 Finland
Other congenital malformations of abdominal wall
+∞
6.3
6
*
Q79.18
ICD-10 Finland
Other congenital malformations of diaphragm
+∞
6.3
6
*
L82
ICPC
Congenital anomaly musculoskeletal
+∞
6.3
6
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.9
6.3
36
130
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.1
6.2
32
108
C09CA06
ATC
candesartan; oral
2.0
6.2
89
502
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
6.2
115
712
R07.3
ICD-10 Finland
Other chest pain
2.6
6.2
43
173
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
5.9
6.2
16
28
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.4
6.2
28
86
S83.0
ICD-10 Finland
Dislocation of patella
4.0
6.2
23
60
N05CF02
ATC
zolpidem; oral
2.0
6.2
85
473
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
4.8
6.2
19
41
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.8
6.1
37
139
J01MA14
ATC
moxifloxacin; systemic
2.8
6.1
37
139
L17
ICPC
Foot/toe symptom/complaint
1.8
6.1
114
705
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.0
6.1
18
37
EB1WA
NOMESCO Finland
NA
12.7
6.1
10
8
K07.61
ICD-10 Finland
Cracking jaw joint
4.3
6.1
21
51
R52.0
ICD-10 Finland
Acute pain
3.8
6.1
24
66
JAF10
NOMESCO Finland
Repair of umbilical hernia
6.8
6.1
14
21
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.9
6.1
23
61
N02CC02
ATC
naratriptan; oral
5.3
6.1
17
33
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
10.2
6.1
11
11
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.7
6.0
16
29
N02CD01
ATC
erenumab; parenteral
6.2
6.0
15
25
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.5
6.0
26
77
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
26
14
19.46
32.80
1.7
3.0
%
123.4
114.4
0.20
26
14
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
324
1851
2.88
31.32
8.4
6.1
mmol/l
1.2
1.2
2.37
279
1592
(3033658) Prothrombin time (PT) actual/Normal
211
1007
2.80
28.16
5.6
3.8
%
97.5
96.1
0.37
206
983
(42870588) Differential panel, method unspecified - Blood
268
1460
2.66
27.28
6.5
6.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
289
1651
2.61
26.43
8.5
5.7
mmol/l
1.2
1.2
3.14
268
1527
(3036481) Cortisol [Moles/volume] in Serum or Plasma
122
447
3.23
25.99
2.2
2.1
nmol/l
340.0
373.7
1.16
106
424
(3002582) Erythrocytes [#/volume] in Urine
231
1194
2.63
25.85
4.5
2.8
e6/l
469.4
56.6
0.58
191
883
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
309
1841
2.59
25.60
3.5
2.3
nmol/l
76.5
73.6
1.07
286
1710
(3037522) Nuclear Ab [Titer] in Serum
160
690
2.87
25.52
1.5
1.4
titre
318.2
524.4
1.35
22
144
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
25
21
12.43
24.89
1.2
1.0
%
121.2
138.0
0.72
25
21
(3012095) Magnesium [Moles/volume] in Serum or Plasma
137
550
3.00
24.83
4.0
3.6
mmol/l
0.8
0.8
1.15
123
518
(3018418) pH of Serum or Plasma
210
1054
2.62
24.75
3.3
3.6
ph
7.4
7.4
0.12
37
199
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
249
1359
2.54
24.57
4.7
2.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
355
2293
2.60
24.29
7.3
5.9
e9/l
0.5
0.5
0.24
318
2000
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
252
1390
2.52
24.23
2.5
1.7
pmol/l
99.5
97.0
0.36
146
745
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
22
11.87
24.17
1.1
1.0
%
106.3
100.0
0.54
11
15
(3006315) Basophils [#/volume] in Blood
355
2302
2.58
23.94
7.3
5.9
e9/l
0.0
0.0
0.02
318
2005
(3019069) Monocytes/100 leukocytes in Blood
343
2190
2.55
23.89
7.4
6.1
%
7.9
8.0
0.60
329
2068
(3006504) Eosinophils/100 leukocytes in Blood
341
2174
2.54
23.78
7.2
5.9
%
2.6
2.8
0.46
325
2033
(3018010) Neutrophils/100 leukocytes in Blood
349
2252
2.55
23.67
7.0
5.7
%
55.7
55.7
0.01
336
2127
(3000850) Epithelial cells [#/volume] in Urine
174
811
2.69
23.65
3.1
2.4
e6/l
7.1
8.8
0.60
155
703
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
435
3128
3.01
23.65
8.4
6.3
u/l
76.3
76.9
0.08
414
2951
(3030467) Casts [#/volume] in Urine by Automated count
211
1083
2.56
23.50
4.6
2.7
e6/l
0.1
0.3
4.52
170
778
(3019198) Lymphocytes [#/volume] in Blood
362
2384
2.57
23.38
7.3
5.9
e9/l
2.1
2.1
0.03
327
2124
(3023368) Bacteria identified in Blood by Culture
169
783
2.69
23.18
5.1
3.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
350
2278
2.52
23.03
7.2
5.9
%
30.5
30.3
0.16
335
2144
(3013115) Eosinophils [#/volume] in Blood
361
2385
2.55
22.97
7.6
6.3
e9/l
0.2
0.2
0.63
327
2115
(3018095) Leukocytes [#/volume] in Urine
262
1498
2.45
22.96
5.4
3.2
e6/l
62.8
77.2
0.12
201
966
(3022096) Basophils/100 leukocytes in Blood
330
2094
2.48
22.91
7.3
6.1
%
0.6
0.7
0.46
314
1958
(3013826) Glucose [Moles/volume] in Serum or Plasma
349
2274
2.51
22.83
6.0
4.3
mmol/l
6.0
6.3
2.69
335
2051
(36304419) Bacteria [Presence] in Urine
210
1096
2.50
22.35
4.4
2.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
224
1212
2.45
21.94
7.2
6.0
inr
1.1
1.1
0.64
78
408
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
23
21
11.40
21.68
1.1
1.0
%
97.4
106.8
—
9
14
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
56
138
4.41
21.16
6.5
4.7
g/l
3.0
3.4
1.65
51
133
(3013650) Neutrophils [#/volume] in Blood by Automated count
382
2648
2.51
20.99
9.2
8.5
e9/l
4.1
3.9
0.81
347
2302
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
196
1020
2.45
20.69
2.2
2.0
u/l
148.6
210.8
0.41
188
969
(3031040) Bacteria [#/volume] in Urine by Automated count
402
2893
2.52
19.68
5.8
3.9
e6/l
611.3
664.2
—
6
38
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
136
609
2.65
19.59
4.2
2.5
e6/l
4.9
3.6
0.45
73
304
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
310
2003
2.29
19.38
5.8
5.5
umol/l
10.3
10.6
0.14
296
1884
(3026782) Osmolality of Urine
156
753
2.51
19.18
3.7
2.4
mosm/kgh2o
541.4
554.4
0.28
137
639
(3022948) Iron [Moles/volume] in Serum or Plasma
127
558
2.67
18.95
3.1
2.3
umol/l
14.7
14.4
0.19
118
515
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
139
639
2.58
18.91
4.0
2.4
e6/l
0.9
0.9
0.00
77
333
(3015171) Extractable nuclear Ab [Units/volume] in Serum
68
211
3.54
18.60
1.3
1.3
u/ml
0.2
0.9
—
7
13
(3044889) 12 lead EKG panel
378
2683
2.36
18.49
3.3
2.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
108
444
2.79
18.29
3.1
2.4
%
23.9
23.9
0.01
95
381
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
245
1473
2.21
17.83
3.7
3.0
u/l
33.8
27.9
0.39
239
1418
(3024561) Albumin [Mass/volume] in Serum or Plasma
250
1516
2.21
17.80
5.4
4.3
g/l
36.1
36.8
1.17
238
1432
(3004789) Transferrin [Mass/volume] in Serum or Plasma
113
498
2.60
16.58
3.1
2.2
g/l
2.5
2.4
0.14
103
459
(3013707) Erythrocyte sedimentation rate by Westergren method
427
3266
2.47
16.53
5.0
3.8
mm/h
9.3
9.3
0.02
403
3070
(3048689) Calprotectin [Mass/mass] in Stool
143
709
2.38
16.26
2.9
2.3
ug/g
105.3
93.7
0.18
110
565
(3003396) Base excess in Arterial blood by calculation
79
292
3.00
16.17
6.1
7.4
mmol/l
1.0
1.1
0.10
59
231
(3036489) Thrombin time
57
174
3.54
15.94
3.6
3.9
s
20.3
21.4
1.16
50
154
(3037467) Urinalysis macro (dipstick) panel - Urine
406
3080
2.28
15.33
5.7
3.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
91
375
2.72
15.19
1.4
1.3
u/ml
193.3
253.8
0.26
83
348
(3028192) IgG subclass 2 [Mass/volume] in Serum
28
51
5.74
14.92
1.3
1.2
g/l
2.4
2.7
0.33
22
35
(4062490)
28
51
5.74
14.92
1.4
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
28
51
5.74
14.92
1.3
1.2
g/l
5.6
6.1
0.60
21
36
(3024139) IgG subclass 3 [Mass/volume] in Serum
28
51
5.74
14.92
1.3
1.2
g/l
0.4
0.4
0.06
21
36
(40758558) Short blood count panel - Blood
194
1135
2.11
14.46
7.2
6.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
112
523
2.44
14.40
1.4
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
299
2053
2.02
14.26
10.6
8.4
e9/l
0.0
0.0
0.16
249
1660
(3005719) IgG [Mass/volume] in Serum or Plasma
84
344
2.71
14.15
3.3
2.5
g/l
9.6
9.7
0.15
77
316
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
183
1057
2.11
14.03
3.6
2.1
mg/l
2.5
2.8
1.49
155
913
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
135
695
2.26
13.82
2.4
3.1
ng/l
934.5
777.6
0.16
108
564
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
201
1210
2.05
13.73
3.5
2.4
u/l
51.9
54.4
0.52
188
1134
(3016502) Oxygen saturation in Arterial blood
68
254
2.92
13.59
7.0
7.9
%
96.1
95.8
0.13
68
249
(3042936) Bacteria identified in Isolate by Culture
108
509
2.40
13.55
2.1
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
213
1320
2.01
13.34
3.0
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
314
2230
1.98
13.19
4.3
3.2
estimate
0.0
0.0
0.00
70
446
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
17
6
29.18
13.03
1.1
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
311
2209
1.96
12.98
6.1
4.4
estimate
0.0
0.0
0.50
68
460
(3035350) Ketones [Presence] in Urine by Test strip
310
2200
1.96
12.96
4.2
3.1
estimate
0.0
0.0
0.00
69
441
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
171
993
2.06
12.72
2.9
2.1
mg/l
1.4
0.7
0.69
126
737
(3000991) Gas panel - Venous blood
73
294
2.71
12.66
13.8
8.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
207
1290
1.98
12.60
3.0
3.0
mmol/l
2.3
2.4
0.84
189
1171
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
76
315
2.64
12.45
4.5
2.7
g/l
0.2
0.2
0.62
70
299
(3021960) Folate [Moles/volume] in Serum or Plasma
143
791
2.10
12.03
1.7
1.4
nmol/l
20.6
21.4
0.23
127
692
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
79
4.24
12.02
1.3
1.4
g/l
0.7
0.5
0.54
24
61
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
23
7.60
11.90
3.5
2.5
u/ml
374.4
635.6
1.09
17
23
(3007853) Bacteria identified in Skin by Aerobe culture
101
491
2.30
11.70
1.7
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
193
1207
1.93
11.40
3.5
2.9
ng/l
17.3
24.0
0.85
88
595
(3001122) Ferritin [Mass/volume] in Serum or Plasma
329
2454
1.87
11.07
4.3
2.9
ug/l
61.9
70.4
1.28
308
2323
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
150
869
2.01
11.00
1.5
1.3
iu/ml
41.5
28.1
0.29
38
274
(3000570) Elastase.pancreatic [Mass/mass] in Stool
38
114
3.51
10.89
1.5
1.4
ug/g
331.5
316.1
0.14
17
64
(3052851) Hemolysis interference index of Serum or Plasma
37
110
3.54
10.75
1.9
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
141
3.23
10.72
8.4
10.0
mmol/l
24.2
24.3
0.05
43
135
(3019309) Folate [Moles/volume] in Red Blood Cells
103
524
2.19
10.63
2.1
1.6
nmol/l
1058.6
1148.6
0.38
81
412
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
221
2.77
10.60
1.8
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
80
368
2.38
10.46
2.9
2.5
u/l
32.7
32.5
0.02
69
310
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
127
709
2.03
10.25
1.6
1.5
pmol/l
140566512.7
23697118.2
0.39
106
633
(40768804) Tissue Pathology biopsy report
254
1791
1.79
9.87
2.2
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
185
1187
1.85
9.81
4.4
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
515
4607
3.55
9.81
19.5
10.4
mg/l
19.0
19.4
0.10
433
3480
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
161
989
1.89
9.78
2.9
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
609
2.06
9.67
2.5
2.8
ng/l
795.7
247.6
0.74
62
341
(3002032) Base excess in Venous blood by calculation
72
332
2.35
9.34
10.4
5.5
mmol/l
1.6
1.7
0.09
60
246
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
974
1.86
9.17
3.8
3.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
45
167
2.85
9.08
8.7
9.2
%
0.6
0.7
0.29
45
167
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
444
3760
2.02
8.93
5.2
4.2
pmol/l
14.4
14.4
0.08
416
3527
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
141
856
1.88
8.76
1.4
1.3
u/ml
10.9
11.3
0.02
53
342
(3028626) Oxygen [Partial pressure] in Capillary blood
43
159
2.85
8.73
10.1
5.1
kpa
9.0
9.0
0.01
43
148
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
281
2089
1.72
8.69
4.6
3.9
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
38
132
3.02
8.62
1.4
1.8
—
253.3
—
0
6
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
44
167
2.78
8.52
9.0
9.2
%
1.1
1.4
1.04
44
167
(40760892) CBC W Ordered Manual Differential panel - Blood
174
1138
1.78
8.44
4.2
4.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
67
3.86
8.43
1.7
2.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
74
362
2.21
8.34
2.5
2.2
au/ml
20.6
20.6
—
8
22
(3014007) Fractional oxyhemoglobin in Arterial blood
43
164
2.76
8.25
9.1
9.4
%
94.5
94.3
0.09
43
164
(3024928) Oxygen saturation in Venous blood
24
64
3.88
8.15
17.0
10.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
137
2.91
8.08
9.1
9.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
87
459
2.07
8.07
4.1
3.1
umol/l
5.4
5.8
0.19
75
386
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
14
8.00
8.01
1.2
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
70
343
2.20
7.85
3.5
2.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
59
270
2.33
7.77
8.8
4.7
mmol/l
1.6
1.3
0.31
50
193
(3019230) Fractional oxyhemoglobin in Venous blood
22
57
3.98
7.77
18.3
10.7
%
73.9
66.8
1.14
22
57
(3003327) Ova and parasites identified in Stool by Light microscopy
48
202
2.51
7.59
2.0
1.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
62
293
2.26
7.58
11.5
13.5
inr
1.0
1.2
—
8
53
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
37
4.71
7.45
1.2
2.9
—
—
—
0
0
(3009343) pH of Capillary blood
59
279
2.25
7.20
8.8
4.6
ph
7.4
7.4
—
5
23
(3011412) CD3 cells [#/volume] in Blood
20
52
3.96
7.04
1.1
2.9
e9/l
1.6
1.4
0.37
14
26
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
29
97
3.10
7.03
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
59
282
2.23
7.02
8.9
4.5
kpa
5.4
5.1
1.59
59
262
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
40
162
2.59
6.85
1.6
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
232
1718
1.61
6.73
4.2
3.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
56
267
2.22
6.71
5.8
4.1
ng/l
64.9
69.7
0.21
50
246
(3021901) Oxygen saturation in Capillary blood
20
54
3.81
6.69
2.1
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
79
3.27
6.65
2.0
2.4
g/l
134.3
132.8
0.15
19
58
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
74
3.35
6.63
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
74
3.35
6.63
1.5
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
81
447
1.96
6.59
1.8
1.5
iu/l
21.4
23.1
0.18
65
380
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
37
147
2.63
6.59
1.3
1.2
—
17.6
—
0
11
(3002256) Pathology report gross observation
91
523
1.89
6.56
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
35
136
2.68
6.51
1.2
1.2
—
18.1
—
0
28
(3019060) Gas panel - Arterial blood
37
148
2.61
6.50
3.5
4.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
340
2.07
6.50
1.9
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
67
348
2.06
6.46
2.3
3.7
%
1.5
1.7
1.82
58
311
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
514
4739
2.76
6.41
12.4
8.5
u/l
24.8
24.3
0.22
504
4619
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
28
98
2.96
6.30
1.1
1.3
—
1.2
—
0
9
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
43
188
2.40
6.29
1.9
2.5
ng/l
90.3
107.1
0.21
35
168
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
67
352
2.03
6.26
4.8
3.6
pmol/l
4.9
4.7
0.30
58
313
(3019150) Specific gravity of Urine by Refractometry
146
978
1.68
6.22
3.6
3.1
kg/l
1.0
1.0
0.21
20
142
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
346
2.03
6.20
2.0
1.6
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
10
8
12.70
6.10
3.4
2.3
mmol/l
16.4
22.3
—
10
8
(3035637) Corticotropin [Mass/volume] in Plasma
20
58
3.54
6.06
1.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
55
273
2.13
5.97
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
38
161
2.46
5.95
1.6
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
55
274
2.12
5.91
2.6
3.7
mmol/l
1.2
1.2
0.34
43
236
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
80
3.09
5.87
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
195
2.31
5.80
2.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
24
5.09
5.77
1.2
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
477
4303
1.93
5.75
6.2
4.8
mu/l
1.6
2.0
0.81
460
4088
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
33
134
2.56
5.65
1.2
1.2
—
3.1
—
0
17
(3007164) IgA [Mass/volume] in Serum or Plasma
172
1228
1.59
5.59
1.8
1.4
g/l
2.0
2.0
0.01
112
746
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
86
513
1.80
5.49
2.1
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
169
2.34
5.37
1.8
2.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
50
250
2.10
5.33
4.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
450
4012
1.73
5.33
15.1
8.9
ml/min/173m2
95.4
92.3
2.64
390
3210
(3029075) Extractable nuclear Ab panel - Serum
11
22
5.08
5.28
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
79
468
1.81
5.15
1.4
1.3
iu/ml
75.2
167.8
2.87
34
200
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
454
4068
1.73
5.15
3.8
3.5
mmol/l
5.6
5.6
0.56
417
3811
(3029937) Albumin [Presence] in Urine by Test strip
161
1151
1.57
5.14
4.3
3.4
estimate
0.0
0.0
0.80
70
455
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
23
4.86
5.03
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
163
2.29
4.90
1.3
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
163
2.29
4.90
1.6
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
76
458
1.77
4.68
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
129
902
1.57
4.47
2.3
2.6
umol/l
300.4
4572.8
2.87
117
815
(3013512) EKG study
128
895
1.56
4.43
3.5
3.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
55
3.16
4.39
1.8
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
58
328
1.86
4.39
4.2
4.9
%
0.4
1.0
1.70
11
97
(3025159) Blasts/100 leukocytes in Blood
54
299
1.90
4.36
4.3
5.1
%
0.0
0.2
—
10
76
(40767503) Oxygen content in Capillary blood by calculation
18
61
3.02
4.32
1.9
2.7
%
17.6
16.5
0.71
13
30
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
22
85
2.66
4.19
1.6
2.2
ug/l
167.8
173.6
0.03
15
76
(3041096) Erythrocytes [Presence] in Urine by Automated
175
1323
1.48
4.17
4.0
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
74
458
1.71
4.15
1.6
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
217
2.01
4.14
11.9
4.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
52
3.14
4.11
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
52
3.14
4.11
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
52
3.14
4.11
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
37
183
2.10
4.09
2.9
2.1
nmol/l
6.1
10.4
2.19
31
169
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
72
445
1.71
4.06
2.5
2.1
u/l
5060.6
3323.4
0.26
24
181
(40761511) CBC panel - Blood by Automated count
513
4841
2.19
4.02
16.5
9.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
180
1377
1.46
4.01
1.4
1.4
u/ml
0.6
1.9
2.57
42
356
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
14
6.52
3.99
3.3
2.0
ug/l
142.6
131.3
—
9
14
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
53
3.08
3.99
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
53
3.08
3.99
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
53
3.08
3.99
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
12
33
3.70
3.94
6.7
7.3
mg/l
12.0
10.8
0.36
12
27
(3023520) Reticulocytes [#/volume] in Blood
44
236
1.94
3.92
2.5
3.1
e9/l
69.9
73.8
0.40
34
169
(44813793)
14
44
3.24
3.80
1.2
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
34
3.59
3.78
1.2
2.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
34
3.59
3.78
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
52
300
1.81
3.71
3.5
4.5
%
0.1
0.7
—
9
70
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
184
2.02
3.67
1.9
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
65
402
1.70
3.66
4.2
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
45
250
1.87
3.62
1.4
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
48
273
1.83
3.59
2.4
2.2
—
—
—
0
0
(4010399)
47
266
1.84
3.57
1.6
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
9
7.86
3.57
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
9
7.86
3.57
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
9
7.86
3.57
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
9
7.86
3.57
1.1
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
53
312
1.77
3.55
4.4
5.0
%
0.0
0.1
—
10
88
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
94
646
1.55
3.47
1.6
1.5
%
1.5
1.3
1.14
79
594
(3000492) Spirometry study
68
432
1.66
3.47
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
139
1045
1.44
3.31
2.9
2.9
mmol/l
7.7
8.1
0.31
124
915
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
96
2.35
3.31
1.4
2.0
g/l
3.6
3.7
0.09
17
80
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
96
2.35
3.31
1.4
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
47
273
1.79
3.30
1.6
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
43
3.07
3.27
1.4
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
6
7
8.65
3.27
3.7
3.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
532
5165
3.03
3.26
27.4
15.6
e9/l
268.7
265.0
0.68
526
5059
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
55
336
1.71
3.25
2.3
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
38
655
0.55
3.24
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
66
2.63
3.24
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
31
158
2.02
3.21
1.1
1.2
—
—
—
0
0
(4198724)
10
28
3.62
3.21
1.3
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
88
607
1.54
3.19
2.7
2.4
mmol/l
2.4
2.4
0.15
76
535
(3020891) Body temperature
22
98
2.30
3.17
5.4
4.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
44
3.00
3.15
1.4
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
53
324
1.70
3.13
1.4
1.6
mu/l
306.3
316.9
0.14
46
297
(3010813) Leukocytes [#/volume] in Blood
532
5171
2.94
3.13
27.4
15.6
e9/l
6.8
6.7
0.95
524
5054
(3026361) Erythrocytes [#/volume] in Blood
532
5169
2.97
3.12
27.3
15.6
e12/l
4.5
4.5
0.07
525
5061
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
153
2.02
3.11
1.2
1.1
—
—
—
0
0
(44790047)
12
39
3.12
3.10
1.5
1.4
—
—
—
0
0
(44790049)
12
39
3.12
3.10
1.5
1.4
—
—
—
0
0
(44806118)
12
39
3.12
3.10
1.5
1.4
—
—
—
0
0
(44790048)
12
39
3.12
3.10
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
44
256
1.78
3.08
3.3
3.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
21
93
2.31
3.07
3.6
4.4
%
0.9
0.9
0.09
21
88
(3006653) Thiamine [Moles/volume] in Blood
8
16
5.06
3.06
1.0
1.5
nmol/l
135.0
142.4
—
8
16
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
155
1.99
3.01
1.9
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
52
323
1.67
2.91
1.5
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
20
89
2.30
2.90
3.5
3.5
mmol/l
1.9
1.1
1.20
20
89
(3027008) Opiates [Presence] in Urine
55
348
1.65
2.87
1.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
55
348
1.65
2.87
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
53
2.69
2.81
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
55
350
1.64
2.81
1.5
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
38
218
1.80
2.80
1.5
1.6
u/l
9.5
10.4
0.15
29
182
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
85
599
1.50
2.80
2.1
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
31
3.27
2.78
1.8
4.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
125
2.05
2.75
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
353
3154
1.34
2.70
4.1
2.9
u/l
33.9
35.7
0.25
332
3031
(3011648) Oxygen content in Venous blood
10
32
3.17
2.66
4.6
17.7
%
14.5
11.7
—
10
32
(3015235) Bicarbonate [Moles/volume] in Capillary blood
19
87
2.23
2.60
2.8
3.1
mmol/l
25.7
24.6
0.87
19
74
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
50
2.64
2.55
1.5
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
10
33
3.07
2.54
1.3
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
20
95
2.15
2.52
4.1
4.4
%
1.7
1.7
0.07
20
89
(3044941) Cell count panel - Synovial fluid
11
39
2.86
2.49
1.5
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
403
3695
1.36
2.46
4.5
4.3
mmol/mol
36.0
37.8
5.14
372
3510
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
51
2.59
2.46
1.1
1.2
nmol/l
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
299
1.63
2.43
3.2
2.1
ml/min/173m2
72.7
77.9
0.30
20
118
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
592
0.60
2.41
1.6
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
8
6.30
2.37
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
52
2.54
2.37
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
277
1.64
2.37
1.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
8
22
3.67
2.37
7.4
2.0
mmol/l
42.8
34.7
—
8
22
(3027944) Amphetamines [Presence] in Urine
52
342
1.58
2.35
1.3
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
18
85
2.16
2.31
1.6
1.3
—
—
—
0
0
(4306422)
17
79
2.19
2.27
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
18
3.92
2.26
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
87
2.11
2.19
2.1
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
10
5.03
2.07
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
147
1.81
2.06
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
17
83
2.08
2.03
2.3
2.6
ph
7.4
7.4
0.13
12
71
(3035320) C reactive protein [Mass/volume] in Body fluid
9
32
2.84
2.01
3.3
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
23
396
0.56
2.00
1.4
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
157
1.76
1.96
1.1
1.1
u/ml
9.9
5.7
0.45
18
96
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
120
1.87
1.95
1.6
1.4
u/ml
237.0
177.5
0.48
13
72
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
113
1.89
1.94
1.1
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
16
3.78
1.94
1.2
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
99
768
1.35
1.93
2.3
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
85
2.03
1.92
1.8
2.2
nmol/l
0.9
0.8
0.19
17
74
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
65
2.18
1.89
1.4
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
172
1445
1.28
1.89
1.8
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
34
2.67
1.87
1.1
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
18
325
0.54
1.85
1.6
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
145
1.76
1.84
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
17
3.56
1.84
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
12
4.19
1.82
2.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
87
1.99
1.81
3.3
4.1
%
50.4
56.5
1.21
17
87
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
102
1.89
1.78
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
103
1.88
1.74
1.4
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
355
0.58
1.73
1.6
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
13
3.87
1.72
1.6
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
13
3.87
1.72
1.6
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
48
2.32
1.71
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
55
2.21
1.68
1.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
97
1.89
1.68
1.4
1.1
—
—
—
0
0
(4035726)
46
320
1.48
1.66
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
31
2.60
1.66
1.1
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
31
2.60
1.66
1.8
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
19
326
0.57
1.66
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
19
326
0.57
1.66
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
19
326
0.57
1.66
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
27
166
1.66
1.65
1.2
1.2
u/ml
1.5
3.2
0.50
16
81
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
24
143
1.71
1.64
1.5
1.5
nmol/l
0.2
0.4
1.57
19
119
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
98
1.87
1.63
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
550
0.67
1.62
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
91
1.90
1.62
1.4
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
132
1093
1.27
1.61
2.1
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
152
1.68
1.59
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
50
2.22
1.58
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
50
2.22
1.58
1.8
1.3
—
—
—
0
0
(3019225) pH of Specimen
46
324
1.46
1.57
3.4
3.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
24
145
1.69
1.57
1.7
1.6
iu/ml
0.1
0.0
—
5
25
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
85
1.91
1.56
3.4
3.6
e9/l
3.3
4.4
2.08
16
85
(3012501) Base excess in Blood by calculation
14
71
2.00
1.55
2.4
2.5
mmol/l
2.2
2.8
—
9
43
(3009542) Hematocrit [Volume Fraction] of Blood
466
4453
1.34
1.55
21.1
11.2
%
40.2
39.9
0.44
380
3697
(3011897) Casein IgE Ab [Units/volume] in Serum
7
27
2.61
1.52
1.0
2.0
—
10.5
—
0
8
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
51
2.18
1.51
1.8
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
51
2.18
1.51
1.8
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
51
2.18
1.51
1.8
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
267
0.55
1.50
1.5
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
148
1.65
1.46
1.1
1.1
u/ml
0.8
0.7
0.06
13
81
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
80
1.90
1.46
1.5
2.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
52
2.14
1.45
1.8
1.3
—
—
—
0
0
(1002224) Polysomnography panel
33
221
1.53
1.45
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
59
2.06
1.44
1.1
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
408
0.64
1.43
1.4
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
39
2.33
1.43
1.3
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
275
0.57
1.43
1.6
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
88
1.84
1.43
1.4
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
67
515
1.34
1.41
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
40
2.27
1.40
1.2
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
23
2.63
1.37
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
17
2.96
1.36
1.8
3.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
75
1.89
1.35
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
10
47
2.15
1.34
1.1
1.1
mg/l
22.6
27.5
—
10
36
(3001019) Free T4 and TSH panel - Serum or Plasma
28
412
0.66
1.32
1.5
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
15
83
1.83
1.32
1.5
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
41
0.00
1.31
0.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
18
106
1.72
1.31
1.2
1.4
u/ml
94.7
113.1
—
7
23
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
43
2.11
1.31
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
24
2.52
1.30
1.2
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
139
1186
1.23
1.30
2.3
2.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
10
48
2.10
1.28
1.4
1.4
pmol/l
269.8
660.4
—
10
38
(3005033) Fetal Nuchal fold Thickness US
16
266
0.59
1.28
1.5
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
163
1.56
1.25
5.9
2.7
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
25
2.42
1.24
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
25
2.42
1.24
1.2
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
45
2.02
1.24
1.0
1.0
mg/l
197.1
190.0
—
9
40
(3003338) MCHC [Mass/volume]
441
4215
1.25
1.23
23.6
13.1
g/l
332.5
332.7
0.17
441
4191
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
93
1.74
1.22
1.0
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
19
2.65
1.22
1.4
1.7
—
42.7
—
0
13
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
19
2.65
1.22
1.2
1.5
—
15.2
—
0
6
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.0
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
26
2.32
1.19
1.2
2.8
e9/l
0.2
0.1
—
6
26
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
38
2.12
1.19
1.0
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
38
2.12
1.19
1.3
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
94
1.72
1.18
1.4
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
79
1.79
1.18
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
235
0.58
1.17
1.4
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.8
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
20
2.51
1.15
1.4
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
41
302
1.39
1.15
2.0
2.5
e9/l
3.7
4.1
0.54
32
257
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
30
2.35
1.12
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
31
2.27
1.10
1.1
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
21
2.39
1.09
1.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
186
1.48
1.08
2.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
52
1.94
1.06
1.9
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
146
1.53
1.05
1.2
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
60
1.85
1.03
2.0
2.1
u/ml
86.1
4.2
0.46
11
51
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
99
1.63
1.01
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
107
1.61
1.00
1.3
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
23
2.18
0.98
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
124
1.55
0.98
1.3
1.8
—
—
—
0
0
(4281824)
7
36
1.96
0.97
1.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
50
1.81
0.97
1.3
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
51
1.78
0.95
1.3
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
37
1.90
0.94
1.1
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
55
1.83
0.92
1.3
1.6
—
—
—
0
0
(4024509)
6
28
2.16
0.91
1.3
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.91
1.8
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
21
143
1.49
0.91
1.5
1.4
u/l
25.9
19.6
0.42
16
123
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
19
277
0.67
0.91
1.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
71
1.71
0.89
5.6
6.2
u/ml
0.3
0.4
—
6
41
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
42
1.92
0.89
1.7
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
42
1.92
0.89
1.3
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
17
111
1.55
0.88
1.0
1.1
u/ml
1.1
2.4
—
6
55
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
138
1223
1.17
0.86
1.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
39
301
1.32
0.85
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
438
4227
1.19
0.85
4.1
3.8
mmol/l
2.9
2.9
0.20
409
4001
(40768441) Liver Pathology biopsy report
6
31
1.95
0.84
2.2
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
202
0.63
0.84
1.3
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
57
1.77
0.84
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
164
1.42
0.81
2.0
2.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.81
1.1
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
167
1511
1.15
0.79
1.6
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
48
387
1.26
0.77
6.4
4.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
59
1.71
0.76
1.7
2.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
59
1.71
0.76
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
83
712
1.20
0.76
1.6
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
207
0.67
0.74
2.1
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
38
1.85
0.73
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
25
2.01
0.73
2.2
1.6
ug/l
17.9
31.2
—
5
25
(40760888) Immunoglobulin light chains.free panel - Serum
7
39
1.81
0.72
3.3
5.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.72
1.3
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
84
1.56
0.72
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
265
1.30
0.72
1.6
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
85
976
0.85
0.71
1.7
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
195
1.35
0.71
3.5
2.7
ug/l
0.5
0.8
1.68
15
110
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
26
1.93
0.71
1.0
1.2
miu/ml
1343.4
1551.6
—
5
26
(4027681)
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
118
1.46
0.70
1.3
2.3
e6/l
17.4
159.0
1.38
12
93
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
118
1.46
0.70
1.3
2.2
e6/l
1.3
6.8
1.35
12
89
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
433
4197
1.16
0.68
3.8
3.5
mmol/l
4.7
4.8
0.27
412
4003
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
27
1.86
0.68
1.4
2.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
431
4178
1.16
0.67
3.7
3.5
mmol/l
1.5
1.5
1.86
404
3970
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
156
1.36
0.62
1.8
1.9
iu/l
2.9
6.0
—
9
55
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
30
1.67
0.61
1.4
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
20
0.00
0.60
0.0
2.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
20
0.00
0.60
0.0
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
117
1055
1.14
0.59
1.5
1.7
mmol/l
1.5
1.4
0.52
100
935
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
107
1187
0.88
0.57
1.8
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
186
1.30
0.55
1.5
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
38
1.59
0.54
1.2
1.7
pg
34.3
32.4
—
6
38
(3032773) Endomysium IgG Ab [Titer] in Serum
12
83
1.46
0.52
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
109
1.39
0.51
1.4
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
101
1.40
0.50
1.4
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
101
1.40
0.50
2.6
1.3
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
7
47
1.50
0.47
1.1
1.2
nmol/l
24.6
35.3
—
7
37
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
86
1.40
0.45
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
267
1.21
0.43
3.1
4.2
ug/l
2.7
7.4
1.67
23
212
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
1.2
3.9
ug/l
0.7
1.9
—
5
31
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
31
1.62
0.43
1.2
1.1
—
79.0
—
0
6
(4268621)
8
58
1.38
0.41
2.8
2.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
60
1.34
0.40
1.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
89
812
1.12
0.39
2.3
3.2
mg/l
1665.3
231.5
0.66
48
537
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
409
3999
1.09
0.37
3.5
3.2
mmol/l
1.3
1.2
1.50
384
3793
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
70
1.29
0.37
1.3
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
79
0.63
0.35
2.2
2.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
43
1.40
0.35
2.3
5.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
118
1.28
0.33
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
118
1.28
0.33
1.3
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
157
1.22
0.30
1.7
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
78
844
0.91
0.29
1.8
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
56
1.25
0.29
1.1
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
56
1.25
0.29
1.0
1.1
—
5.8
—
0
9
(3020682) Albumin/Creatinine [Ratio] in Urine
91
847
1.09
0.29
2.7
3.9
mg/mmol
5.5
10.5
1.00
53
546
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
384
1.13
0.28
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
63
1.27
0.28
1.5
2.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
72
0.69
0.26
1.8
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
263
1.15
0.26
4.5
3.9
%
23.9
22.6
—
9
113
(3034274) Bile acid [Moles/volume] in Serum --fasting
16
132
1.22
0.26
4.5
2.8
umol/l
7.0
7.3
0.04
16
101
(1761868) Lipid panel - Serum or Plasma
166
1730
0.94
0.24
2.3
2.3
—
—
—
0
0
(4034850)
16
133
1.21
0.24
8.1
6.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
385
3916
0.94
0.24
4.1
3.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
143
1.19
0.23
2.3
3.2
g/l
0.3
0.3
—
6
67
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
124
0.80
0.22
1.1
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
42
1.19
0.21
1.0
1.1
—
0.2
—
0
8
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
3.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.5
—
0.8
—
0
10
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
(4094501)
10
81
1.24
0.19
1.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
62
1.13
0.17
1.6
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
412
0.92
0.17
3.2
3.4
%
32.7
31.8
0.19
29
297
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
364
1.08
0.13
1.4
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
127
0.86
0.12
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
133
1.13
0.12
2.0
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
143
1.12
0.11
2.1
2.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
83
0.84
0.07
3.3
1.9
%
12.1
13.2
—
7
83
(3021879) Hepatitis B virus core Ab [Presence] in Serum
47
452
1.04
0.07
1.7
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
100
1.10
0.05
1.0
1.1
u/ml
12.5
7.6
—
6
46
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
27
258
1.05
0.05
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
62
612
1.01
0.01
1.7
2.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
263
1.03
0.01
2.0
1.7
mg/l
3.6
3.0
0.24
19
170
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
116
0.95
0.00
1.0
1.1
u/ml
4.2
7.1
—
6
45
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
24
245
0.98
0.00
1.9
1.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
16
156
1.03
0.00
1.5
1.4
pmol/l
52.3
68.9
1.08
16
151
(46235355) HIV 1 and 2 tests - Meaningful Use set
149
1485
1.00
0.00
2.1
2.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
76
0.92
0.00
1.1
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
52
0.96
0.00
1.0
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
6.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
51.6
—
0
6
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.6
—
843.2
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
14.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
79
1.01
0.00
12.4
3.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
6
63
0.95
0.00
1.3
1.5
—
10.6
—
0
7
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
76
0.92
0.00
1.6
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED | 2.061 [1.59, 2.68] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.094 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 2142 females with Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED | 2.024 [1.48, 2.77] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.045 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 1126 males with Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.212% | 0.457% |
| 5 | 1.159% | 2.853% |
| 10 | 2.828% | 6.949% |
| 15 | 5.402% | 12.6% |
| 20 | 9.606% | 20.54% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_MUSCULOS_SYSTEM_NOT_ELSEW_CLASSIFIED – Congenital malformations of the musculoskeletal system, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data